Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone.
Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone.
The Torcetrapib project was terminated on December 2, 2006 due to safety findings.

 To look at ultrasound images taken in the carotid arteries and to look at various lipids in
 the blood of people with heterozygous familial hypercholesterolemia
For additional information please call: 1-800-718-1021
Inclusion Criteria:

 -  Diagnosis of Heterozygous Familial Hypercholesterolemia

 -  At least 18 years of age

 Exclusion Criteria:

 -  Women who are pregnant or lactating, or planning to become pregnant.

 -  Subjects with a clinically indicated need for statin (HMG-CoA reductase inhibitor)
 therapy other than atorvastatin or other concomitant therapy with known lipid altering
 effects on LDL-C and HDL-C including fibrates and nicotinic acid (high doses)

 -  Subjects taking any drugs known to be associated with an increased risk of myositis in
 combination with HMG-CoA reductase inhibitors

 -  Subjects with any other medical condition or laboratory abnormality which could affect
 subject safety, preclude evaluationof response, or render unlikely that the subject
 would complete the study